Skip to main content
Clinical Trials/IRCT20110425006280N14
IRCT20110425006280N14
Recruiting
Phase 3

Comparison of efficacy and safety of two muscle relaxants cisatracurium and succinylcholine in Electroconvulsive therapy; A randomized, single-blind clinical trial study

Rasht University of Medical Sciences0 sites62 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
62
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients 18 years and older
  • Normal body mass index
  • No criteria for difficult mask ventilation
  • No contraindication for cisatracurium and succinylcholine

Exclusion Criteria

  • myasthenia gravis
  • History of malignant hyperthermia
  • History of burns
  • Kidney failure
  • Guillain\-Barré syndrome
  • Any nerve denervation
  • Dangerous arrhythmias

Outcomes

Primary Outcomes

Not specified

Similar Trials